Health and Life Sciences news
Rebecca Zolotor has been promoted to dean and vice president of Purdue Global’s School of Health Sciences, effective Oct. 1.
Purdue University has received $2.7 million in federal funding from the U.S. Department of Agriculture’s Animal and Plant Health Inspection Service (APHIS) to develop a field test that can measure and predict the spread of SARS-CoV-2, the virus that causes COVID-19, in a wide range of wildlife and farm animals.
A new cancer therapy developed by Purdue University researchers attacks tumors by tricking cancer cells into absorbing a snippet of RNA that naturally blocks cell division. As reported today in Oncogene, tumors treated with the new therapy did not increase in size over the course of a 21-day study, while untreated tumors tripled in size over the same time period.
When you shell out for artisanal food – Swiss Gruyère cheese, organic vanilla extract, Italian prosciutto – did you get what you paid for? With global food fraud estimates as high as $40 billion a year, it’s a question Purdue University researchers are tackling with a food “fingerprint” technique sensitive enough to distinguish between foods made from the same ingredients, but in different locations.
Decades of research have left knowledge gaps about cells that regulate the immune system: Purdue and NIH
Four decades of research have produced a vast pool of knowledge about regulatory T cells, a subset of our immune cells. Even so, scientists at Purdue University and the National Institutes of Health have identified 14 understudied T-reg proteins that merit increased attention for the molecular roles they play in disease onset.
To amplify the impact made by its faculty, staff, students and alumni, the Purdue Research Foundation and Purdue University have formed Purdue Innovates, a comprehensive system to streamline access to both (a) technology commercialization resources, such as intellectual property licensing and protection, and (b) startup support resources, including programs to launch, scale and invest in Purdue-connected startups in one cohesive structure.
Early COVID-19 pandemic suspicions about dogs’ resistance to the disease have given way to a long-haul clinical data gap as new variants of the virus have emerged.